Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors

J Clin Oncol. 2013 Mar 1;31(7):976-7. doi: 10.1200/JCO.2012.47.0351. Epub 2013 Jan 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dacarbazine / administration & dosage*
  • Dacarbazine / analogs & derivatives*
  • Female
  • Humans
  • Male
  • Neuroendocrine Tumors / drug therapy*

Substances

  • Dacarbazine